BCL2 and neoplasm: Studies have reported that introducing miR-34a mimics into the NSCLC model triggers upregulation of p53 and downregulation of the B-cell lymphoma-2 (Bcl-2) gene, thereby enhancing tumor apoptosis and facilitating effective tumor ablation [16, 17].